LADENBURG THALMANN FINANCIAL SERVICES INC. - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 46 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q3 2019$8,0000.0%9,995
+5.3%
0.00%
Q2 2019$8,000
+33.3%
9,495
+35.7%
0.00%
Q1 2019$6,0000.0%6,9950.0%0.00%
Q4 2018$6,000
-53.8%
6,9950.0%0.00%
Q3 2018$13,000
+62.5%
6,995
+70.8%
0.00%
Q2 2018$8,0000.0%4,0950.0%0.00%
Q1 2018$8,000
+14.3%
4,095
+104.8%
0.00%
Q3 2016$7,0000.0%2,0000.0%0.00%
Q2 2016$7,000
-73.1%
2,0000.0%0.00%
Q1 2015$26,0002,0000.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2019
NameSharesValueWeighting ↓
CARL DOMINO INC 58,435$190,0000.18%
VAN DEN BERG MANAGEMENT I, INC 165,900$584,0000.07%
Granite Investment Partners, LLC 141,206$497,0000.04%
ORACLE INVESTMENT MANAGEMENT INC 50,804$179,0000.03%
JW Asset Management, LLC 8,500$30,0000.02%
Psagot Value Holdings Ltd. 55,362$195,0000.01%
Financial Architects, Inc 5,056$18,0000.01%
B. Riley Wealth Advisors, Inc. 48,226$19,0000.00%
Virtu KCG Holdings LLC 43,205$152,0000.00%
Edge Wealth Management LLC 2,000$7,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders